FDA draft guidance encourages inclusion of male patients in breast cancer clinical trials

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

FDA has published a draft guidance, Male Breast Cancer: Developing Drugs for Treatment, which includes recommendations for inclusion of males in breast cancer clinical trials.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login